Allogeneic Hematopoietic Cell Transplantation Outcomes After Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma (CA209-039 and CheckMate 205)

View/Open

Supporting information (63.31Kb)

Publication Date

2017-09

ICR Author

Marsden,

Author

Carlo-Stella, C

Collins, GP

Armand, P

Zinzani, PL

Cohen, JB

Halwani, A

Millenson, M

Provencio, M

Domenech, ED

Giulino-Roth, L

Castagna, L

Kato, K

McKiver, MP

Sumbul, A

Zhu, L

Trneny, M

Minnema, MC

Rueda, A

Cunningham, D

Reddy, N

Younes, A

Santoro, A

Type

Journal Article

Metadata

Show full item record

URL

https://repository.icr.ac.uk/handle/internal/1379

Collections

• Other ICR Research

Version of record

10.1016/j.clml.2017.07.136

License start date

2017-09

Citation

Clinical Lymphoma Myeloma and Leukemia, 2017, 17 pp. S326 - S327